Yvan Renaud

Symbiotics is the leading market access platform for impact investing, dedicated to private markets in emerging and frontier economies. The group offers investment, asset management and capacity building services. Since 2005, we have originated over 7,300 investments representing more than USD 9.2 billion for 570 companies in 95 countries. We manage an aggregate portfolio of USD 2.9 billion spread across 23 funds and mandates. Our portfolio companies have also benefited from over 145 technical assistance projects worth more than USD 18 million.